Glaucoma, a leading cause of blindness, silently damages the optic nerve, often progressing unnoticed until irreversible vision loss occurs. Early detection through comprehensive eye exams is crucial, ...

Conjunctivitis may mimic other types of serious eye conditions such as glaucoma, iritis, keratitis, and corneal ulcer. Typically, conjunctivitis causes only pain, redness, and drainage, with redness ...

While reviewing patient cases with residents one morning, Joseph F. Rizzo III, MD, mentioned he recently cared for a patient who had taken semaglutide and developed severe optic neuropathy. One ...

Glaucoma represents one of medicine’s most paradoxical challenges—a leading cause of irreversible blindness worldwide that progresses so silently many patients have no idea they’re affected until ...

Men and patients with particular clinical characteristics are more likely to present with angle closure glaucoma of greater severity. Severe visual field (VF) loss is more common at the first ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Open Enrollment Help. Medicare can be complicated. But it doesn ...

HONOLULU (KHON2) — Stress can affect many parts of your body, including your eyes. When you feel stressed, your body releases hormones like cortisol and adrenaline. These hormones prepare you for a ...

Traditional angle closure glaucoma management, including LPI, is being challenged due to limited evidence of efficacy in preventing visual field loss. The ZAP study suggests LPI's limited prophylactic ...

Patients with osteoporosis who use bisphosphonates to manage the condition are at increased risk for acute angle closure glaucoma. In patients with osteoporosis, bisphosphonate use, particularly ...

The use of bisphosphonates, particularly risedronate, in patients with osteoporosis is linked to a higher risk for acute angle closure but not open-angle glaucoma. Researchers conducted a ...

Using zebrafish and mice, scientists from the University of Cambridge have shown that a common glaucoma drug might be able to protect the brain from the buildup of tau protein, which has been ...